COMPANY

Assurance Infusion

Assurance Infusion: recalling firm for BPC-157, CJC-1295, Ipamorelin, as stated by public registers.

RECALLING FIRM

Recalled a product naming the peptide (FDA enforcement report).

BPC-157Class II recall, Terminated, 2020-01-22 Regulator openFDA
CJC-1295Class II recall, Terminated, 2020-01-22 Regulator openFDA
IpamorelinClass II recall, Terminated, 2020-01-22 Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.